WINTON GROUP Ltd Invests $4.64 Million in HealthEquity, Inc. $HQY

Key Points

• WINTON GROUP Ltd bought 51,336 HealthEquity shares worth approximately $4.64 million, joining several other institutions that initiated or increased positions. Institutional investors collectively own 99.55% of the company.
• HealthEquity exceeded quarterly expectations, reporting $1.24 EPS versus the $1.19 consensus and $350.73 million in revenue, up 95.5% year over year. The company issued fiscal 2027 EPS guidance of $4.66–$4.73.
• Analysts maintain a generally positive view, giving HealthEquity a consensus “Moderate Buy” rating and an average price target of $111.87. Meanwhile, insiders sold 12,456 shares worth roughly $1.26 million over the past 90 days.

WINTON GROUP Ltd bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 51,336 shares of the company's stock, valued at approximately $4,637,000. WINTON GROUP Ltd owned approximately 0.06% of HealthEquity as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Sivia Capital Partners LLC purchased a new stake in HealthEquity during the second quarter worth approximately $306,000. Arrowstreet Capital Limited Partnership purchased a new position in shares of HealthEquity in the 2nd quarter valued at $4,747,000. Marshall Wace LLP purchased a new position in shares of HealthEquity in the 2nd quarter valued at $5,483,000. Amundi lifted its holdings in shares of HealthEquity by 9.3% during the 2nd quarter. Amundi now owns 30,203 shares of the company's stock valued at $3,059,000 after acquiring an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC acquired a new position in shares of HealthEquity during the 2nd quarter valued at $449,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Fiore sold 2,354 shares of HealthEquity stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the sale, the executive vice president directly owned 52,244 shares in the company, valued at $4,963,180. The trade was a 4.31% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian Dillon sold 7,632 shares of the company's stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares in the company, valued at approximately $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,456 shares of company stock worth $1,256,664 over the last 90 days. 1.60% of the stock is owned by company insiders.

HealthEquity Stock Up 2.0%

Shares of HealthEquity stock opened at $94.55 on Friday. The business has a 50-day moving average of $99.58 and a 200-day moving average of $89.18. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The company has a market capitalization of $7.82 billion, a PE ratio of 34.13, a P/E/G ratio of 1.46 and a beta of 0.22. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The business had revenue of $350.73 million for the quarter, compared to analyst estimates of $349.22 million. The firm's revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, equities analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

Analysts Set New Price Targets

HQY has been the subject of several recent research reports. Citigroup reiterated a "market outperform" rating on shares of HealthEquity in a report on Friday, August 28th. Barrington Research restated an "outperform" rating and set a $110.00 price objective on shares of HealthEquity in a research note on Friday, May 22nd. BTIG Research reaffirmed a "buy" rating and issued a $115.00 target price on shares of HealthEquity in a research report on Friday, August 28th. Royal Bank Of Canada raised their target price on HealthEquity from $100.00 to $108.00 and gave the company an "outperform" rating in a report on Wednesday, June 3rd. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of HealthEquity in a research report on Wednesday, September 2nd. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, HealthEquity presently has a consensus rating of "Moderate Buy" and a consensus target price of $111.87.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.